Chronic idiopathic dyspepsia;Dyspepsie chronique idiopathique

Hepato-Gastro

Volumn 7, Issue 5, 2000, Pages 373-382

  Ducrotte, P ^a   Maillot, C ^a   Savoye, G ^a  

^a HÔPITAL CHARLES NICOLLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CISAPRIDE; FEDOTOZINE; OCTREOTIDE; PLACEBO; SEROTONIN 1 ANTAGONIST; SIMETHICONE; STOMACH SECRETION INHIBITOR;

DYSPEPSIA; ERADICATION THERAPY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY; HELICOBACTER PYLORI; HUMAN; HYPERSENSITIVITY; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW;

EID: 0033786228     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. Dyspepsia and heartburn : A clinical challenge
2. Decision-making in dyspepsia: Controversies in primary and secondary care
3. Predominant symptoms identify different subgroups in functional dyspepsia
4. Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population
5. Three-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: Results from the Domestic/International Gastroenterology Surveillance Study (Digest)
6. Current concepts in dyspepsia
7. Management of uninvestigated and functional dyspepsia: A working party report for the World Congresses of Gastroenterology 1998
8. The impact of functional gastrointestinal disorders on quality of life
9. Estimating the cost of lost productivity in dyspepsia
10. The health economic impact of upper gastrointestinal symptoms in the general population: Results from the Domestic/International Gastroenterology Surveillance Study (Digest)
11. Tumor-related dysmotility. Gastrointestinal dysmotility syndromes associated with tumors
12. Evolution of acute cytomegalovirus gastritis to chronic gastrointestinal dysmotility in a nonimmunocompromised adult
13. An unusual cause of gastroparesis: Demyelinating disease of the medulla
14. Gastroparesis after celiac plexus block
15. Screening for drug related dyspepsia: An analysis of prescription symmetry
16. Relationship between upper gastrointestinal symptoms and life style, psychological factors and comorbidity in the general population: Results from the Domestic/International Gastroenterology Surveillance Study (Digest)
17. Does endoscopy have a positive impact on quality of life in dyspepsia ?
18. Patterns of endoscopy use in the United States
19. Overuse of upper gastrointestinal endoscopy in a country with open-access endoscopy: A prospective study in primary care
20. AGA medical position statement: Evaluation of dyspepsia
21. Risk indicators of organic diseases in uninvestigated dyspepsia: A one-week survey in 246 Italian endoscopy units
22. Does concern about missing malignancy justify endoscopy in uncomplicated dyspepsia in patients aged less than 55 ?
23. Gastric cancer and other endoscopic diagnosis in patients with benign dyspepsia
24. How should Helicobacter pylori positive dyspeptic patients be managed ?
25. Prospective screening of dyspeptic patients by Helicobocter pylori serology
26. Endoscopy far Helicobacter pylori sero-negative young dyspeptic patients: An economic evaluation based on a randomized trial
27. Guidelines for the management of dyspepsia
28. A prospective randomized trial of a 'test and treat' policy versus endoscopy based management in young Helicobacter pylori positive patients with ulcer-like dyspepsia, referred to a hospital clinic
29. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia
30. Management of dyspepsia in primary care
31. Disturbed solid-phase gastric emptying in functional dyspepsia: A meta-analysis
32. Ambulatory gastro-jejunal manometry in severe motility-like dyspepsia: Lack of correlation between dysmotility, symptoms, and gastric emptying
33. Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia
34. Contractile patterns in patients with severe chronic dyspepsia
35. Postprandial duodenojejunal motility in health and idiopathic severe gastroparesis: From conventional analysis to nonlinear dynamics analysis
36. Impaired postprandial gastric slow waves in patients with functional dyspepsia
37. Abnormalities of the electrogastrogram in functional gastrointestinal disorders
38. Gastric myoelectrical activity and gastric emptying in patients with functional dyspepsia
39. Pitfalls in the analysis of electrogastrographics recordings
40. Edrophonium provocative testing during electrogastrography (EGG): Effects on dyspeptic symptoms and the EGG
41. Role of impaired gastric accomodation to a meal in functional dyspepsia
42. Response to gastric distension in functional dyspepsia
43. Gastric accomodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function
44. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting
45. Sulfamethizole capsules containing contrast medium for assessment of gastric emptying in functional dyspepsia patients
46. Measurement and evaluation of gastric emptying using radiopaque barium markers
47. 13C-octanoic acid breath test for gastric emptying measurement
48. Development of a test to measure gastric accommodation in humans
49. Symptoms and visceral perception in severe functional and organic dyspepsia
50. Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients
51. Relationship of Helicobacter pylori infection with gastrointestinal motility
52. Influence of H. pylori infection on gastric motor and sensory function in asymptomatic volunteers
53. The effect of Helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with non-ulcer dyspepsia
54. Influence of bacterial CagA status on gastritis, gastric function indices, and pattern of symptoms in H. pylori-positive dyspeptic patients
55. Management of dyspepsia in general practice: A clinical assessment
56. Motility-modifying agents and management of disorders of gastrointestinal motility
57. The influence of cisapride on gastric tone and the perception of gastric distension
58. The effect of cisapride on dysmotility-like functional dyspepsia: Reduction of the fasting and postprandial area, but not the post-prandial antral expansion
59. The effect of cisapride on dyspepsia symptoms and the electrogastrogram in patients with non-ulcer dyspepsia
60. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia
61. Influence of sumatriptan on gastric fundus tone and on the perception of gastric distension in man
62. The effect of erythromycin on gastric emptying is modified by physiological changes in the blood glucose concentration
63. Effects of somatostatin on proximal gastric motor function and visceral perception
64. Octreotide in refractory functional epigastric pain with nutritional impairment: An open study
65. Differential effects of amitryptyline on perception of somatic and visceral stimulation in healthy humans
66. Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsia
67. Tricyclic antidepressants for functional nausea and vomiting: Clinical outcome in 37 patients
68. Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia
69. Efficacy and safely of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia
70. Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment: A multicentre 3-month follow-up study
71. First line treatment with omeprazole provides an effective and superior alternative strategy in the management of dyspepsia compared to antacid/alginate liquid: A multicentre study in general practice
72. Low-dose lansoprazole provides greater relief of heartbum and epigastric pain than low-dose omeprazole in patients with acid-related dyspepsia
73. Is Helicobacter pylori associated with non-ulcer dyspepsia and will eredication improve symptoms ? A meta-analysis
74. Symptomatic benefit from eradicating Helicobacter pylori infedion in patients with nonulcer dyspepsia
75. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
76. Eradication of Helicobacter pylori in functional dyspepsia: Randomised double blind placebo controlled trial with 12 month's fellow-up
77. Conference de cansensus Helicobacter pylori. Revision 1999: Conclusions et recommandations revisees du groupe de travail
78. Dyspepsia and health care seeking in a community: How important are psychological factors ?
79. What makes the dyspeptic patients feel ill ? A cross sectional survey of functional heath status, Helicobacter pylori infection, and psychological distress in dyspeptic patients in general practice
80. Does fear of serious disease predict consulting behaviour amongst patients with dyspepsia in general practice ?
81. Effect of mental stress and cisapride on autonomic nerve functions in functional dyspepsia